Phase 3, randomized, open-label, comparative study of standard whole brain radiation therapy with supplemental oxygen, with or without concurrent RSR13 (efaproxiral [Efaproxyn]), in women with brain metastases from breast cancer.
Phase of Trial: Phase III
Latest Information Update: 09 May 2013
At a glance
- Drugs Efaproxiral (Primary)
- Indications Advanced breast cancer; Brain metastases; Cancer metastases
- Focus Registrational; Therapeutic Use
- Acronyms ENRICH
- 01 Mar 2011 Additional locations identified as reported by ClinicalTrials.gov.
- 02 Nov 2007 Status changed from in progress to completed.
- 30 Aug 2006 Status change
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History